Cellebrite Earnings Call Highlights Growth, Cash Strength

Cellebrite Di Ltd. ((CLBT)) has held its Q4 earnings call. Read on for the main highlights of the call.

Cellebrite’s latest earnings call struck a confident tone, as management highlighted robust growth in annual recurring revenue, expanding margins, and powerful free cash flow generation. While acknowledging temporary headwinds in U.S. federal business, FX, and recent acquisitions, executives emphasized a clear path to faster ARR growth and durable, high-30s free cash flow margins over time.

Strong ARR Growth Underpins the Investment Case

ARR climbed 21% to $481 million in 2025, including the Keryllium acquisition, underscoring the resilience of Cellebrite’s subscription engine. Excluding Keryllium, ARR still advanced a healthy 17% year over year, with a 6% sequential uptick in Q4 and a $16.1 million ARR boost from Keryllium after its December 1 close.

Revenue and Profitability Track Ahead of Plan

Fourth-quarter revenue grew 18% to $128.8 million, with full-year revenue up 19% to $475.7 million as demand remained broad-based. Profitability expanded even faster, with Q4 adjusted EBITDA jumping 33% to $38.3 million and margins widening to 29.8%, while full-year adjusted EBITDA reached $127.6 million, a 26.8% margin.

Free Cash Flow Engine and Balance Sheet Strength

Cellebrite’s cash generation stood out, with 2025 free cash flow of $160 million, up 30% from the prior year and equal to a 34% margin. Despite deploying $147 million of net cash for Keryllium, the company still ended 2025 with $535 million in cash, equivalents and investments, giving it ample strategic and financial flexibility.

SaaS, Cloud and Guardian Drive High-Value Mix Shift

SaaS and cloud ARR grew more than 50% and now make up 22% of total ARR, reflecting accelerating adoption of recurring, software-first solutions. Guardian extended its streak to six consecutive quarters of triple-digit growth and is increasingly becoming a central evidence repository for public-safety and government customers.

Insights Conversion and Forensics Technology Leadership

Management reported converting 55% of the installed digital forensics base to its Insights platform, surpassing a 50% target and reinforcing stickiness. The company is also investing heavily in mobile research to deepen its Android leadership and regain the lead in iOS, with new capabilities slated to hit the market in roughly six weeks.

Strategic Acquisitions Broaden Product and Market Reach

The acquisition of Keryllium adds ARM virtualization technology that management views as uniquely positioned in digital forensics, expected to enhance product depth and differentiation. Cellebrite also announced the planned purchase of SCG Canada, a drone-forensics specialist with a low single-digit million ARR run-rate, for an anticipated $15–$20 million.

Diversified Geographic Growth and Solution Mix Upgrade

Growth was well balanced geographically, with ARR rising 19% in the Americas, 24% in EMEA and 23% in Asia Pacific, highlighting the global need for digital intelligence tools. Higher-growth offerings such as Pathfinder, Guardian and Keryllium accounted for 14% of ARR at year-end 2025, with management aiming for roughly 20% by the end of 2026.

U.S. Federal Disruptions and FedRAMP Delays as Temporary Drags

The U.S. federal unit was a rare weak spot, posting roughly flat performance in 2025 and creating an estimated four-point headwind to ARR growth versus the original plan. Management tied part of the softness to protracted FedRAMP and ATO processes, which delayed federal cloud and Guardian penetration but are expected to normalize as approvals are secured.

FX Volatility and Integration Costs Weigh Modestly on Margins

A stronger Israeli shekel versus the U.S. dollar created a meaningful foreign-exchange headwind that shaved roughly one to two points off margins. Additionally, incremental integration and operating expenses from Keryllium compressed margins by about one point, though management expects these impacts to fade as revenue scales in 2026.

Disciplined Capital Deployment and Integration Commitments

The December closing of Keryllium required a $147 million net cash outlay, demonstrating Cellebrite’s willingness to deploy capital for strategic technology assets. The upcoming acquisition of SCG Canada, expected to cost about $15–$20 million, adds another integration project but is viewed as a focused tuck-in that broadens the company’s reach into drone forensics.

Conservative Guidance Leaves Upside from AI Monetization

Executives signaled a more conservative approach to guidance with notably tighter ranges, reflecting better visibility but also a cautious stance. They also highlighted that potential upside from future AI-driven, agent-based applications is not embedded in 2026 forecasts, suggesting room for performance to exceed current expectations if monetization gains traction.

2026 Outlook and Forward Guidance Signal Confidence

For full-year 2026, Cellebrite guided to ARR of $567–$573 million, implying 18%–19% growth versus 2025, and revenue of $565–$571 million, a 19%–20% increase. Adjusted EBITDA is projected at $149–$155 million, or a 26%–27% margin, with free cash flow margins expected above 30%, roughly 60% of EBITDA generated in the back half and an ambition to reach a rule-of-x score in the upper 40s toward 50.

Cellebrite’s earnings call painted the picture of a company balancing aggressive innovation and M&A with disciplined profitability and cash generation. With core ARR growth solid, cloud and Guardian momentum strong, and a conservative guidance posture that excludes potential AI upside, the setup for 2026 and beyond appears attractive for investors watching the digital forensics and public-safety software space.